Dimenhydrinate

Dimenhydrinate Recall

Get an alert when a recall is issued.

Questions & Answers

Side Effects & Adverse Reactions

Do not use in children under 2 years of age unless directed by a doctor

Ask a doctor before use if you have

glaucoma
a breathing problem such as emphysema or chronic bronchitis
difficulty in urination due to enlargement of the prostate gland

Ask a doctor or pharmacist before use if you are taking sedatives or tranquilizers

When using this product

marked drowsiness may occur
avoid alcoholic drinks
alcohol, sedatives and tranquilizers may increase drowsiness
be careful when driving a motor vehicle or operating machinery

if pregnant or breast-feeding, ask a health professional before use,

Legal Issues

There is currently no legal information available for this drug.

FDA Safety Alerts

There are currently no FDA safety alerts available for this drug.

Manufacturer Warnings

There is currently no manufacturer warning information available for this drug.

FDA Labeling Changes

There are currently no FDA labeling changes available for this drug.

Uses

For prevention and treatment of these symptoms associated with motion sickness:

Nausea
Vomiting
diziness

History

There is currently no drug history available for this drug.

Other Information

There are no additional details available for this product.

Sources

Dimenhydrinate Manufacturers

Qualitest Pharmaceuticals

Dimenhydrinate | Qualitest Pharmaceuticals

to prevent motion sickness, the first dose should be taken ½ to 1 hour before starting activity to prevent or treat motion sickness, use the following dosing Adults and children 12 years and over 1-2 tablets every 6-8 hours; not more than 3 tablets in 24 hours, or as directed by a doctor Children 6 years to under 12 years ½-1 tablet every 6 – 8 hours, not more than 3 tablets in 24 hours, or as directed by a doctor Children 2 years to under 6 years ¼- ½ tablet every 6-8 hours, not more than 11/2 tablets in 24 hours, or as directed by a doctor

No Recall
Contract Pharmacal Corp

Dimenhydrinate | Contract Pharmacal Corp

Other information: store at room temperature, USP
Each tablet contains 29 mg of calcium

No Recall
App Pharmaceuticals, Llc

Dimenhydrinate | App Pharmaceuticals, Llc

Dimenhydrinate in the injectable form is indicated when the oral form is impractical.
Adults
Nausea or vomiting may be expected to be controlled for approximately 4 hours with 50 mg, and prevented by a similar dose every 4 hours. Its administration may be attended by some degree of drowsiness in some patients, and 100 mg every 4 hours may be given in conditions in which drowsiness is not objectionable or is even desirable.
For intramuscular administration, each milliliter (50 mg) of solution is injected as needed, but for intravenous administration, each milliliter (50 mg) of solution must be diluted in 10 mL of 0.9% Sodium Chloride Injection, USP and injected over a period of 2 minutes.
Pediatric
For intramuscular administration, 1.25 mg/kg of body weight or 37.5 mg/m2 of body surface area is administered four times daily. The maximum dose should not exceed 300 mg daily (see CONTRAINDICATIONS).
Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit.
Adults
Nausea or vomiting may be expected to be controlled for approximately 4 hours with 50 mg, and prevented by a similar dose every 4 hours. Its administration may be attended by some degree of drowsiness in some patients, and 100 mg every 4 hours may be given in conditions in which drowsiness is not objectionable or is even desirable.
For intramuscular administration, each milliliter (50 mg) of solution is injected as needed, but for intravenous administration, each milliliter (50 mg) of solution must be diluted in 10 mL of 0.9% Sodium Chloride Injection, USP and injected over a period of 2 minutes.
Pediatric
For intramuscular administration, 1.25 mg/kg of body weight or 37.5 mg/m2 of body surface area is administered four times daily. The maximum dose should not exceed 300 mg daily (see CONTRAINDICATIONS).
Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit.

No Recall
Qualitest Pharmaceuticals

Dimenhydrinate | Qualitest Pharmaceuticals

to prevent motion sickness, the first dose should be taken 1/2 to 1 hour before starting activity to prevent or treat motion sickness, use the following dosing
adults and children
12 years and over
1-2 tablets every 4-6 hours; not more than
8 tablets in 24 hours, or as directed by a doctor
children 6 years to
under 12 years
1/2-1 tablet every 6-8 hours; not more than
3 tablets in 24 hours, or as directed by a doctor
children 2 years to
under 6 years
1/4-1/2 tablet every 6-8 hours; not more than
1 1/2 tablets in 24 hours, or as directed by a doctor

No Recall
Time Cap Labs, Inc

Dimenhydrinate | Time Cap Labs, Inc

irections:

To prevent motion sickness, the first dose should be taken one-half to one hour before starting activity.

Adults and children 12 years of age and over - 1 to 2 tablets every 4 to 6 hours, not to exceed 8 tablets in 24 hours, or as directed by a doctor

Children 6 to under 12 years of age 1/2 to 1 tablet every 6 to 8 hours, not to exceed 3 tablets in 24 hours, or as directed by a doctor

Children 2 to under 6 years of age - 1/4 to 1/2 tablet every 6 to 8 hours,not to exceed 1 1/2 tablets in 24 hours, or as directed by a doctor

No Recall
A-s Medication Solutions Llc

Dimenhydrinate | A-s Medication Solutions Llc

to prevent motion sickness, the first dose should be taken 1/2 to 1 hour before starting activity to prevent or treat motion sickness, use the following dosing
adults and children
12 years and over
1-2 tablets every 4-6 hours; not more than
8 tablets in 24 hours, or as directed by a doctor
children 6 years to
under 12 years
1/2-1 tablet every 6-8 hours; not more than
3 tablets in 24 hours, or as directed by a doctor
children 2 years to
under 6 years
1/4-1/2 tablet every 6-8 hours; not more than
1 1/2 tablets in 24 hours, or as directed by a doctor

No Recall
Carilion Materials Management

Dimenhydrinate | Carilion Materials Management

to prevent motion sickness, the first dose should be taken 1/2 to 1 hour before starting activity to prevent or treat motion sickness, use the following dosing
adults and children 12 years and over
1-2 tablets every 4-6 hours; not more than 8 tablets in 24 hours, or as directed by a doctor
children 6 years to under 12 years
1/2-1 tablet every 6-8 hours; not more than 3 tablets in 24 hours, or as directed by a doctor
children 2 years to under 6 years
1/4-1/2 tablet every 6-8 hours; not more than 1 1/2 tablets in 24 hours, or as directed by a doctor

No Recall

Login To Your Free Account